STAT - Reporting from the frontiers of health and medicine

A STAT Investigation

Health

First Opinion

By Guadalupe Hayes-Mota

Biotech Microbiome therapy companies face the fallout of failed Seres trial
Health Tech Researchers analyzed 4,063 papers on tools to help guide care. Only 12 were replications
First Opinion On menthol cigarettes, social justice theory shouldn’t trump science
First Opinion A turning point for children: creating an AIDS-free generation
Health Covid-19 kept families and caregivers out of hospitals. Some doctors think that shouldn’t happen again

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Most clinical trials failed to meet U.S. transparency requirements for recently approved drugs
Pfizer looks to widen access to Covid-19 vaccine in Africa, but advocates say it doesn’t go far enough
Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine

Exclusive

Health

Heavyweights

Health

Prescription Politics

Special Report

Health A new way to visualize the surge in Covid-19 cases in the U.S.
Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
The Readout LOUD How concerned should we be about breakthrough coronavirus infections? One expert weighs in
A STAT Investigation Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients
Health Why is Delta such a big deal? And other burning questions about the next phase of the Covid-19 pandemic
Special Report The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Health The Covid-19 Tracker
First Opinion On menthol cigarettes, social justice theory shouldn’t trump science